Matteo Cornaglia

Matteo Cornaglia is CEO & co-founder of Nagi Bioscience. He holds a PhD in Micro- and Nanotechnologies from EPFL and brings over 10 years of experience developing and commercializing innovative life science solutions. He leads business development, fundraising, and strategic partnerships, driving the translation of advanced microfluidic, robotics, and AI-driven screening platforms into scalable, market-ready new approach methodologies (NAMs).